Harold E. Kim

5.2k total citations · 2 hit papers
17 papers, 3.4k citations indexed

About

Harold E. Kim is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Oncology. According to data from OpenAlex, Harold E. Kim has authored 17 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Otorhinolaryngology and 6 papers in Oncology. Recurrent topics in Harold E. Kim's work include Head and Neck Cancer Studies (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Photodynamic Therapy Research Studies (3 papers). Harold E. Kim is often cited by papers focused on Head and Neck Cancer Studies (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Photodynamic Therapy Research Studies (3 papers). Harold E. Kim collaborates with scholars based in United States, South Korea and Malaysia. Harold E. Kim's co-authors include John F. Ensley, Christopher J. Schultz, Thomas F. Pajak, Jay S. Cooper, Arlene A. Forastiere, Julie A. Kish, Scott Saxman, Anthony J. Cmelak, Mitchell Machtay and Karen K. Fu and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Harold E. Kim

17 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

2004 2.3k citations Jay S. Cooper, Thomas F. Pajak et al. New England Journal of Medicine profile →
Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck

2012 385 citations Jay S. Cooper, Qiang Zhang et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Harold E. Kim United States	15	2.5k	1.7k	1.2k	1.1k	485	17	3.4k
Jean-Louis Lefèbvre France	5	2.9k 1.2×	2.1k 1.2×	1.4k 1.1×	1.2k 1.1×	419 0.9×	6	3.7k
Harlan Pinto United States	14	2.2k 0.9×	1.3k 0.8×	1.0k 0.8×	685 0.6×	459 0.9×	28	2.9k
John Hay Canada	23	1.3k 0.5×	1.1k 0.6×	906 0.7×	948 0.8×	201 0.4×	58	2.4k
A. Trotti United States	7	1.4k 0.6×	918 0.5×	709 0.6×	637 0.6×	491 1.0×	15	2.2k
Stéphane Temam France	33	1.8k 0.7×	1.8k 1.1×	2.0k 1.7×	912 0.8×	947 2.0×	173	4.2k
Timo Atula Finland	28	1.0k 0.4×	949 0.6×	889 0.7×	434 0.4×	316 0.7×	93	2.5k
M. Degardin France	17	1.4k 0.6×	1.0k 0.6×	1.2k 0.9×	838 0.8×	311 0.6×	37	2.3k
Armin Schueler Germany	11	1.8k 0.7×	962 0.6×	2.2k 1.8×	1.6k 1.5×	962 2.0×	18	3.8k
Teresa Guerrero Urbano United Kingdom	25	1.7k 0.7×	964 0.6×	858 0.7×	1.3k 1.2×	305 0.6×	108	3.1k
Daniëlle Van den Weyngaert Belgium	16	1.2k 0.5×	854 0.5×	673 0.6×	735 0.7×	198 0.4×	26	1.8k

Countries citing papers authored by Harold E. Kim

Since Specialization

Citations

This map shows the geographic impact of Harold E. Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harold E. Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harold E. Kim more than expected).

Fields of papers citing papers by Harold E. Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harold E. Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harold E. Kim. The network helps show where Harold E. Kim may publish in the future.

Co-authorship network of co-authors of Harold E. Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Harold E. Kim. A scholar is included among the top collaborators of Harold E. Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harold E. Kim. Harold E. Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

1.

Cho, Won Jin, David Kessel, J Rakowski, et al.. (2021). Photodynamic Therapy as a Potent Radiosensitizer in Head and Neck Squamous Cell Carcinoma. Cancers. 13(6). 1193–1193. 16 indexed citations

2.

Lee, Su Hyun, Won Jin Cho, Abdo J. Najy, et al.. (2021). p62/SQSTM1-induced caspase-8 aggresomes are essential for ionizing radiation-mediated apoptosis. Cell Death and Disease. 12(11). 997–997. 18 indexed citations

3.

Kessel, David, et al.. (2021). Characteristics of an Impaired PDT Response. Photochemistry and Photobiology. 97(4). 837–840. 4 indexed citations

4.

Kessel, David, et al.. (2019). Effects of HPV Status on Responsiveness to Ionizing Radiation vs Photodynamic Therapy in Head and Neck Cancer Cell lines. Photochemistry and Photobiology. 96(3). 652–657. 21 indexed citations

5.

Ali, Arif N., Peixin Zhang, W.K. Alfred Yung, et al.. (2018). NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients. Journal of Neuro-Oncology. 137(1). 39–47. 25 indexed citations

6.

Abdallah, Nadine, et al.. (2018). Radiation therapy and immune-related side effects in patients treated with PD-1 inhibitors.. Journal of Clinical Oncology. 36(5_suppl). 207–207. 21 indexed citations

7.

Jung, Young‐Suk, Abdo J. Najy, Weitong Huang, et al.. (2017). HPV-associated differential regulation of tumor metabolism in oropharyngeal head and neck cancer. Oncotarget. 8(31). 51530–51541. 42 indexed citations

8.

Divi, Vasu, Jonathan Harris, Paul M. Harari, et al.. (2015). Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes, NRG Oncology/RTOG 9501-0234.. Journal of Clinical Oncology. 33(15_suppl). 6011–6011. 4 indexed citations

9.

Wuthrick, Evan, Qiang Zhang, Mitchell Machtay, et al.. (2014). Institutional Clinical Trial Accrual Volume and Survival of Patients With Head and Neck Cancer. Journal of Clinical Oncology. 33(2). 156–164. 180 indexed citations

10.

Cooper, Jay S., Qiang Zhang, Thomas F. Pajak, et al.. (2012). Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck. International Journal of Radiation Oncology*Biology*Physics. 84(5). 1198–1205. 385 indexed citations breakdown →

11.

Christensen, Michael, Greg Dyson, Dev Kamdar, et al.. (2012). Up‐front neck dissection followed by concurrent chemoradiation in patients with regionally advanced head and neck cancer. Head & Neck. 34(12). 1798–1803. 19 indexed citations

12.

Le, Quynh‐Thu, Harold E. Kim, Charles Schneider, et al.. (2011). Palifermin Reduces Severe Mucositis in Definitive Chemoradiotherapy of Locally Advanced Head and Neck Cancer: A Randomized, Placebo-Controlled Study. Journal of Clinical Oncology. 29(20). 2808–2814. 142 indexed citations

13.

Cooper, Jay S., Thomas F. Pajak, Arlene A. Forastiere, et al.. (2004). Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck. New England Journal of Medicine. 350(19). 1937–1944. 2295 indexed citations breakdown →

14.

Lonardo, Fulvio, S. Madan, John R. Jacobs, et al.. (2003). Sclerosing mucoepidermoid carcinoma with eosinophilia of the thyroid: a case report and review of the literature. American Journal of Otolaryngology. 25(1). 48–53. 34 indexed citations

15.

Moon, Aree, Mi-Sung Kim, Tae‐Gyun Kim, et al.. (2000). H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: A role for MMP-2 in the h-ras-induced invasive phenotype. International Journal of Cancer. 85(2). 176–181. 104 indexed citations

16.

Moon, Aree, Mi-Sung Kim, Tae‐Gyun Kim, et al.. (2000). H-ras, but not N-ras, induces an invasive phenotype in human breast epithelial cells: A role for MMP-2 in the h-ras-induced invasive phenotype. International Journal of Cancer. 85(2). 176–181. 78 indexed citations

17.

Kim, Harold E., et al.. (1997). Platelet-derived growth factor (PDGF)-signaling mediates radiation-induced apoptosis in human prostate cancer cells with loss of p53 function. International Journal of Radiation Oncology*Biology*Physics. 39(3). 731–736. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact